Caplin Point Laboratories informs about press release

28 Mar 2024 Evaluate
Caplin Point Laboratories has attached a Press Release regarding grant of final approval from the United States Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) Ketorolac tromethamine Ophthalmic Solution 0.5% (eye drops), to its Subsidiary Caplin Steriles.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

1733.00 -8.25 (-0.47%)
22-Jan-2026 13:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.40
Dr. Reddys Lab 1221.20
Cipla 1378.10
Zydus Lifesciences 885.00
Lupin 2176.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×